Free Trial

Rapport Therapeutics (RAPP) SEC Filings & 10K Form

Rapport Therapeutics logo
$18.07 +0.21 (+1.18%)
(As of 12/20/2024 05:16 PM ET)

Recent Rapport Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
2:11 PM
Cormorant Asset Management, LP (Filed by)
Rapport Therapeutics (Subject)
Form SC 13G/A
11/13/2024
11:26 AM
Capital International Investors (Filed by)
Rapport Therapeutics (Subject)
Form SC 13G
11/12/2024
9:34 AM
FMR LLC (Filed by)
Rapport Therapeutics (Subject)
Form SC 13G/A
11/07/2024
5:59 PM
Rapport Therapeutics (Issuer)
Silva Paul M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:00 PM
PEREZ ROBERT J (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:00 PM
Rapport Therapeutics (Issuer)
Young Wendy B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
5:35 PM
Rapport Therapeutics (Issuer)
Silva Paul M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2024
5:45 PM
PEREZ ROBERT J (Reporting)
Rapport Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2024
5:47 PM
Rapport Therapeutics (Issuer)
Sanchez Ramiro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
5:27 PM
Rapport Therapeutics (Issuer)
Young Wendy B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2024
5:31 PM
Rapport Therapeutics (Issuer)
Sanchez Ramiro (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2024
6:30 AM
Rapport Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:15 AM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
4:23 PM
JOHNSON & JOHNSON (Filed by)
Rapport Therapeutics (Subject)
Form SC 13G
08/08/2024
6:40 AM
Rapport Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:20 AM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
9:10 AM
FMR LLC (Filed by)
Rapport Therapeutics (Subject)
Form SC 13G
07/03/2024
7:04 PM
HEALY JAMES (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
8:00 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Rapport Therapeutics (Subject)
Form SC 13G/A
06/21/2024
3:52 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Rapport Therapeutics (Subject)
Form SC 13G
06/10/2024
6:46 PM
ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
Burow Kristina (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:35 PM
Ignelzi Troy A. (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:38 PM
HEALY JAMES (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:39 PM
Ceesay Abraham (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:39 PM
Ceesay Abraham (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:42 PM
Rapport Therapeutics (Issuer)
Third Rock Ventures GP V, LP (Reporting)
Third Rock Ventures GP V, LP (Reporting)
Third Rock Ventures GP VI, L.P. (Reporting)
Third Rock Ventures GP VI, L.P. (Reporting)
Third Rock Ventures V, L.P. (Reporting)
Third Rock Ventures V, L.P. (Reporting)
Third Rock Ventures VI, L.P. (Reporting)
Third Rock Ventures VI, L.P. (Reporting)
TRV GP V, LLC (Reporting)
TRV GP VI, LLC (Reporting)
TRV GP VI, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:42 PM
Rapport Therapeutics (Issuer)
Yeleswaram Krishnaswamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:43 PM
Bredt David (Reporting)
Bredt David (Reporting)
Rapport Therapeutics (Issuer)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:43 PM
Gault Cheryl (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:44 PM
Galer Bradley S. (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:51 PM
Rapport Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/06/2024
11:15 PM
Rapport Therapeutics (Filer)
Form EFFECT
06/06/2024
6:03 PM
HEALY JAMES (Reporting)
Rapport Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2024
6:04 PM
Gault Cheryl (Reporting)
Rapport Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2024
6:06 PM
Rapport Therapeutics (Issuer)
Tong Jeffrey K (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2024
6:07 PM
Galer Bradley S. (Reporting)
Rapport Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2024
6:14 PM
ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
Burow Kristina (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Rapport Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2024
6:29 PM
Huber Reid M (Reporting)
Rapport Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2024
5:49 PM
Ceesay Abraham (Reporting)
Rapport Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2024
5:51 PM
PAUL STEVEN M (Reporting)
Rapport Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2024
5:52 PM
Burrell Terry-Ann (Reporting)
Rapport Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
The #1 Coin for November 2024 (Ad)

Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…
06/06/2024
5:56 PM
MARAGANORE JOHN (Reporting)
Rapport Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2024
5:57 PM
Rapport Therapeutics (Issuer)
Third Rock Ventures GP V, LP (Reporting)
Third Rock Ventures GP VI, L.P. (Reporting)
Third Rock Ventures V, L.P. (Reporting)
Third Rock Ventures VI, L.P. (Reporting)
TRV GP V, LLC (Reporting)
TRV GP VI, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2024
5:59 PM
Rapport Therapeutics (Issuer)
Yeleswaram Krishnaswamy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2024
6:03 PM
Bredt David (Reporting)
Rapport Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2024
5:46 PM
Ignelzi Troy A. (Reporting)
Rapport Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2024
1:28 PM
Rapport Therapeutics (Filer)
Form CERT
06/03/2024
5:08 AM
Rapport Therapeutics (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RAPP) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners